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Introduction
Post-traumatic hemorrhagic shock is the second highest 
cause of early death (1-3). Therefore, to reduce early 
mortality from post-traumatic shock, aggressive treatments, 
such as resuscitation, should be considered. However, 
there have been reports suggesting that the extent of 
tissue damage from ischemic-reperfusion injury due to 
hemorrhagic shock may be exacerbated when oxygen is 
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Background: Hemorrhagic shock and resuscitation (HSR) is known to cause inflammatory reactions in the 
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gas has shown to inhibit the formation and eliminate reactive oxygen species (ROS), which are known to 
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Methods: Rats weighing 300–500 g were divided into three groups: sham, HSR, and hydrogen  
(H2)/HSR groups. In the latter two groups, HSR was induced via femoral vein cannulation. Gas containing 
2% hydrogen gas was inhaled only by those in the H2/HSR group. Lung tissue and abdominal aorta blood 
were obtained for histologic examination and arterial blood gas analyses, respectively. Neutrophil infiltration 
and proinflammatory mediators were also measured.
Results: PO2 was lower in the HSR and H2/HSR groups than in the sham group. Blood lactate level was 
not significantly different between the sham and H2/HSR groups, but it was significantly higher in the 
HSR group. Infiltration of inflammatory cells into the lung tissues was more frequent in the HSR group. 
Myeloperoxidase (MPO) activity was significantly different among the three groups (highest in the HSR 
group). All proinflammatory mediators, except IL-6, showed a significant difference among the three groups 
(highest in the HSR group). 
Conclusions: Inhalation of 2% hydrogen gas after HSR minimized the extent of lung injury by decreasing 
MPO activity and reducing infiltration of inflammatory cells into lung tissue.
Keywords: Hemorrhagic shock and resuscitation (HSR); hydrogen gas; lung injury
Submitted Sep 11, 2018. Accepted for publication Jan 05, 2019.
doi: 10.21037/jtd.2019.03.23
View this article at: http://dx.doi.org/10.21037/jtd.2019.03.23
1527
1520
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2019;11(4):1519-1527jtd.amegroups.com
Moon et al. Hydrogen gas inhalation after HSR
reintroduced into the tissue after resuscitation (4). In other 
words, hemorrhagic shock and resuscitation (HSR), which 
are commonly observed in trauma patients, may cause 
inflammatory reactions in the lung parenchyma, including 
various organs, as well as acute lung injury, which may be 
triggered by HSR, and increase complications of trauma 
patients that can ultimately lead to death (5,6).
Reperfusion injury may be directly related to the 
formation of reactive oxygen species (ROS), damage of 
vascular endothelial cells, increased vascular permeability, 
and activation of neutrophils, platelets, cytokines, and 
complement systems (6). Among these, ROS is known to be 
the most important cause of reperfusion injury.
Antioxidants responsible for the inhibition and 
elimination of ROS have recently been introduced. Medical 
gases, such as hydrogen (H2), oxygen (O2), nitrous oxide 
(N2O), carbon monoxide (CO), nitrogen oxide (NO), 
and hydrogen sulfide (H2S), have been identified as these 
antioxidants (7). H2 in particular have been shown to have 
distinct characteristics, including its antioxidative effect on 
specific ROS and excellent diffusion capacity (7,8). The 
purpose of this study was to investigate the protective effect 
of 2% inhaled hydrogen gas on lung injury after HSR. 
Methods
Animals
All surgical procedures and animal care were carried out 
in accordance with the Laboratory Animals Welfare Act, 
the Guide for the Care and Use of Laboratory Animals, 
as well as the Guidelines and Policies for Swine Survival 
Surgery, provided by the Institutional Animal Care and Use 
Committee of the Ajou University Health System. Rats 
weighing 300–500 g (DBL, Chungcheongbuk-do, Korea) 
were used as experimental animals and were divided into 
three groups: the sham group, HSR group, and H2/HSR 
group. 
HSR protocol
All rats were anesthetized with isoflurane-soaked gauzes, 
and the left femoral artery and femoral vein were exposed in 
aseptic condition. The polyethylene tube containing heparin 
was then cannulated into the femoral artery to acquire the 
mean arterial pressure during the experiment and into the 
femoral vein to extract blood while inducing hemorrhagic 
shock and administer blood and fluid during resuscitation. 
Prior to inducing hemorrhagic shock, blood pressure was 
measured in both the HSR and H2/HSR groups, via the 
femoral artery, to determine the reference mean arterial 
pressure. In the HSR and H2/HSR groups, hemorrhagic 
shock was induced by extracting the blood with heparin-
containing syringe (10 units/mL) through the femoral 
vein cannulation for a period of 15 minutes until the mean 
arterial pressure reached 30 mmHg. These hemorrhagic 
shock conditions lasted for 60 minutes, during which, blood 
was further extracted or reintroduced through the femoral 
vein cannulation to maintain a mean arterial pressure 
between 25 and 35 mmHg. After 60 minutes, resuscitation 
was performed by injecting blood and fluid through the 
femoral vein over a period of 15 minutes until the mean 
arterial pressure reached the reference pressure. During 
the experiment, spontaneous breathing was maintained, 
electric blanket was used to maintain body temperature, and 
electrocardiogram and body temperature were continuously 
monitored. After resuscitation, the cannulation tube 
inserted into the femoral artery and femoral vein was 
removed, and the femoral wound was sutured. In the sham 
group, the cannulation tube was inserted for the same 
duration as the HSR and H2/HSR groups; after removing 
the cannulation tube, the femoral wound was sutured.
Two percent hydrogen gas and control gas composition and 
administration
The 2% hydrogen gas was composed of H2 (2%), O2 (21%), 
and nitrogen (N2) (77%); the control gas was composed 
of O2 (21%) and N2 (79%) (Praxair, Dongtan-si, Korea). 
Experimental rats were placed in a sealed plexiglas chamber 
with gas inlet and outlet lines, and 2% hydrogen gas was 
injected into the plexiglas chamber at a rate of 4 L/min. 
Inhalation of the hydrogen gas and control gas was 
performed for 1 hour after inducing hemorrhagic shock and 
for 3 hours after resuscitation. Hydrogen gas was inhaled 
only in the H2/HSR group, and control gas was inhaled in 
the sham and HSR groups (Figure 1). 
Sacrifice of experimental rats and tissue extraction
After the experiment, rats were anesthetized with isoflurane, 
and the abdomen was incised to extract the blood from 
the abdominal aorta. During this procedure, normal saline 
was injected through the inferior vena cava until the blood 
of the abdominal aorta became transparent; at this point, 
lung tissue was extracted and immediately frozen in liquid 
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nitrogen and stored at −80 ℃ until use. Mice died naturally 
during this process.
Arterial blood gas analysis
After HSR, arterial blood was extracted from the 
abdominal aorta. The following parameters were measure 
and compared between the groups via arterial blood gas 
analyses: blood lactate, PO2, and PCO2. 
Histologic examination
Hematoxylin & Eosin (H&E) staining and histologic 
examination were performed to confirm the infiltration of 
inflammatory cells into the lungs. Lung tissue was fixed in 
10% neutral buffered formalin, embedded in paraffin, and 
sectioned. After deparaffinization, the sections of lung tissue 
were stained with H&E and examined using an optical 
microscope. 
Measurement of neutrophil infiltration into the lung tissue
Myeloperoxidase (MPO) activity was measured using 
colorimetric MPO assay kit (BioVision, CA, USA) to 
evaluate neutrophil infiltration into the lung tissue. 
Measurement of proinflammatory mediators
Reverse transcription polymerase chain reaction (RT-PCR) 
was used to measure proinflammatory mediators. The 
expression of IL-1β, IL-6, tumor necrosis factor (TNF)-α, 
inducible nitric oxide synthase (iNOS), intercellular 
adhesion molecule-1 (ICAM-1), and chemokine (C-C 
motif) ligand 2 (CCL2) were measured. 
Figure 1 Experimental diagram and summary. H2, hydrogen; HSR, hemorrhagic shock and resuscitation.
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Statistical analysis
All statistical results were expressed as the mean value ± 
standard error of measurement (SEM). Parametric data 
were analyzed using one-way analysis of variance (ANOVA). 
Comparison of significant interactions and main effects for 
all statistical tests were performed using Bonferroni’s post 
hoc test. All statistical analyses were performed using SPSS 
version 24 (IBM Corp. Released 2016.IBM SPSS Statistics 
for Window, Version 24.0. Armonk, NY, USA: IBM Corp.). 
A P value of less than 0.05 was considered statistically 
significant. 
Results
Arterial blood gas analyses and histologic examination
The PO2 values in the HSR and H2/HSR groups were 
lower than those in the sham group, but without statistical 
significance (Figure 2, Table 1). The PCO2 levels did not 
show statistically significant differences among the all 
groups. There was no statistically significant difference in 
the blood lactate levels between the sham group and the 
H 2/HSR group.  However,  the  HSR group had a 
significantly higher blood lactate level than the Sham and 
Figure 2 Arterial blood gas analysis and blood lactate. Data expressed as mean ± SEM. *, P<0.05. H2, hydrogen; SEM, standard error of 
measurement; HSR, hemorrhagic shock and resuscitation.
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Table 1 Mean value of arterial blood gas analysis and blood lactate
Variables Sham group HSR group H2/HSR group P value
PO2, mmHg 550.06±88.20 206.16±97.74 326.25±86.78 <0.001
a
PCO2, mmHg 48.54±5.21 49.60±4.86 45.83±8.47 0.625
Blood lactate, ng/mL 1.43±0.43 2.53±0.68 1.43±0.13 0.002b
a, Sham group > HSR group, P<0.001; Sham group > HSR group, P=0.003; b, HSR group > Sham group, P=0.006; HSR group > H2/HSR 
group, P=0.006. H2, hydrogen; HSR, hemorrhagic shock and resuscitation.
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H2/HSR groups (Table 1). Infiltration of inflammatory cells 
into the lung tissues was more frequently observed in the 
HSR group than in the sham and H2/HSR groups (Figure 3). 
Measurement of MPO activity and proinflammatory 
mediators
MPO activity was significantly different among the three 
groups; it was the highest in the HSR group, followed by the 
H2/HSR group and the sham group, in that order (Figure 4, 
Table 2). Regarding the proinflammatory mediators in lung 
tissue, all mediators, except for IL-6, were significantly 
different among the three groups. These mediators were 
most commonly observed in the HSR group, followed 
by the H2/HSR group and the sham group, in that order. 
In the case of IL-6, there was no statistically significant 
difference between the sham group and the H2/HSR group; 
however, it was significantly lower in the sham group and 
H2/HSR group compared with the HSR group (Figure 5, 
Table 3).
Discussion
In this study, we demonstrated that 2% hydrogen 
gas inhalation may play an important role in reducing 
inflammatory mediators in lung injury after HSR. The 
lung is the main target organ of inflammatory mediators 
after HSR. These inflammatory mediators cause acute 
lung injury that can eventually result in death. The most 
important substance in this inflammatory reaction is ROS, 
which is known to affect various organs, including the 
lungs (9). Treatment of ROS includes the secretion of 
antioxidants, such as glutathione peroxidase, and superoxide 
dismutase (SOD), in the body, as well as supplementation 
in vitro, such as hydrogen gas. However, studies on the role 
and function of antioxidants injected in vitro have not been 
conducted sufficiently, and this study shows that inhaled 
hydrogen gas may reduce inflammatory mediators.
According to our arterial blood gas analyses, there was 
Figure 3 Inflammatory cells infiltration into the lungs. (The arrows indication of HSR group: inflammatory cells, stain, hematoxylin and 
eosin; magnification, ×100). H2, hydrogen; HSR, hemorrhagic shock and resuscitation.
Sham group                                     H2/hsr group                                 HSR group
Figure 4 Myeloperoxidase activity. Data expressed as mean ± 
SEM. *, P<0.05. SEM, standard error of measurement; H2, 
hydrogen; HSR, hemorrhagic shock and resuscitation; MPO, 
myeloperoxidase.
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Table 2 Mean values of myeloperoxidase activity
Variables Sham group HSR group H2/HSR group P value
MPO activity (mU/mg) 15.25±5.32 52.75±6.90 29.25±9.84 <0.001a
a, HSR group > H2/HSR group, P=0.005; HSR group > Sham group, P<0.001. H2, hydrogen; HSR, hemorrhagic shock and resuscitation; 
MPO, myeloperoxidase.
Figure 5 Proinflammatory mediators (%GAPDH). Data expressed as mean ± SEM. *, P<0.05. SEM, standard error of measurement. 
H2, hydrogen; HSR, hemorrhagic shock and resuscitation; TNF, tumor necrosis factor; iNOS, inducible nitric oxide synthase; ICAM-1, 
intercellular adhesion molecule-1; CCL2, chemokine (C-C motif) ligand 2.
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Table 3 Mean value of proinflammatory mediators (%GAPDH)
Variables Sham group HSR group H2/HSR group P value
TNF-α (pg/mL) 17.31±6.10 332.20±67.80 176.93±64.04 <0.001a
IL-6 (pg/mL) 13.32±6.66 493.28±220.01 220.84±179.24 0.002b
ICAM-1 (pg/mL) 25.21±19.71 264.92±51.01 119.48±19.63 <0.001c
iNOS (pg/mL) 10.42±2.25 219.31±57.09 101.07±2.83 <0.001d
CCL2 (pg/mL) 20.08±9.83 312.34±88.27 143.55±28.78 <0.001e
IL1-β (pg/mL) 15.92±8.59 571.93±186.37 335.98±64.14 <0.001f
a, HSR group > H2/HSR group, P=0.001; HSR group > Sham group, P<0.001; H2/HSR group > Sham group, P=0.001;
 b, HSR group > Sham 
group, P=0.002; c, HSR group > H2/HSR group, P<0.001; HSR group > Sham group, P<0.001; H2/HSR group > Sham group, P=0.001;
  
d, HSR group > H2/HSR group, P<0.001; HSR group > Sham group, P<0.001; H2/HSR group > Sham group, P=0.006;
 e, HSR group >  
H2/HSR group, P<0.001; HSR group > Sham group, P<0.001; H2/HSR group > Sham group, P=0.001;
 f, HSR group > H2/HSR group, 
P=0.005; HSR group > Sham group, P<0.001. H2, hydrogen; HSR, hemorrhagic shock and resuscitation; TNF, tumor necrosis factor; iNOS, 
inducible nitric oxide synthase; ICAM-1, intercellular adhesion molecule-1; CCL2, chemokine (C-C motif) ligand 2.
a lower PO2 level in both the H2/HSR group and HSR 
group when compared with the sham group. This finding 
suggests that HSR causes lung injury and loss of pulmonary 
function. Moreover, our analyses showed that PCO2 was 
not significantly different among the three groups. The 
PCO2 level is known to be elevated toward the end stage 
of lung injury in patients with acute respiratory distress 
syndrome (10). Given that this experiment examined 
acute lung injury, the arterial blood PCO2 levels were not 
different between the groups. Blood lactate levels were 
higher in the HSR group than in the sham group and 
H2/HSR group. Increased blood lactate is known to be a 
strong predictor of multiple organ damage and mortality 
in critically ill patients. Moreover, blood lactate levels in 
patients with acute respiratory distress syndrome are known 
to increase in proportion to the severity of pulmonary 
disease (11). Therefore, elevated blood lactate in the HSR 
group indirectly suggests that there may be greater lung 
injury in the HSR group compared with the sham and 
H2/HSR groups. 
Large infiltration of neutrophils into the lungs indicates 
acute lung injury. MPO activity is a direct measurement of 
the degree of neutrophil infiltration into the lungs and an 
indirect measurement of lung injury (12). We showed that 
MPO activity was lower in the H2/HSR group than in the 
HSR group. In other words, 2% hydrogen gas—to some 
degree—inhibited neutrophil infiltration and minimized the 
degree of lung injury.
A var ie ty  of  in f lammatory  mediators ,  such as 
proinflammatory transcription factors and proinflammatory 
cytokines, are known to be involved in ischemic organ 
damage. Among these, TNF-α and IL-1β are considered as 
initiator cytokines that initiate stepwise activations of other 
mediators, such as activation of other cytokines, release of 
prostaglandin, and induction of chemotaxis of leukocytes 
due to inflammation (13). Therefore, as shown in this 
study, a reduction of TNF-α and IL-1β by 2% hydrogen 
gas inhalation may ultimately reduce the incidence of lung 
injury from the onset of resuscitation. 
It is known that ICAM-1 induces neutrophil infiltration 
into the lungs and CCL2 attracts monocytes into the lungs 
(14,15). In this study, ICAM-1 and CCL2 levels were higher 
in the HSR group than in the H2/HSR group. This suggests 
that neutrophils and monocytes were infiltrated more 
frequently in the HSR group, hence greater progression of 
lung injury.
Although IL-6 may contribute to acute lung injury 
as an inflammatory mediator, it is known that IL-6 
has an anti-inflammatory effect that can suppress the 
development of lung injury, depending on the type of 
receptors (16). However, IL-6 is elevated in all patients 
with acute respiratory distress syndrome or at risk of acute 
respiratory distress syndrome due to infectious, traumatic, 
or inflammatory diseases, and such elevated IL-6 level is 
associated with a higher risk of death (17). Thus, elevated 
IL-6, as a biomarker for pulmonary injury, can be used 
to predict the extent of lung damage in the HSR group. 
However, a definitive conclusion about whether elevated 
IL-6 contributes to lung injury remains unclear. 
iNOS has been reported to have different effects 
depending on the stage of lung injury. In the early stages 
of pulmonary injury, iNOS has been shown to play a 
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proinflammatory role, whereas in the late stages, it has been 
associated with inflammation suppression (18). In this study, 
iNOS, which was increased in the HSR group, behaved as 
a proinflammatory mediator, given that this study examined 
acute, early stage lung injury. 
This study has the following limitation to consider. 
Although the protective effect of 2% inhaled hydrogen gas 
was demonstrated on post-HSR lung injury, the advantages 
of hydrogen gas relative to other medical gases were not 
evaluated. To address this, a future comparative study of 
hydrogen gas versus other medical gases will be necessary.
In conclusion, inhalation of 2% hydrogen gas after 
HSR can minimize the extent of lung injury by inducing a 
decrease in the MPO activity—and consequently inhibiting 
the infiltration of neutrophils into the lungs—and by 
inducing a decrease in the infiltration of inflammatory cells 
into the lung tissues—and consequently suppressing the 
formation of proinflammatory mediators, such as IL-1β, 
TNF-α, iNOS, ICAM-1 and CCL2. Although it has not 
been applied in clinical practice, the administration of 
hydrogen gas through a ventilator, nasal cannula, or simple 
inhalation in traumatic hemorrhagic patients is expected to 
reduce the extent of lung injury.
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